Ownership history in SCHULHOFF & CO INC · 21 quarters on record
This page tracks every 13F SEC filing in which SCHULHOFF & CO INC reported a position in AVADEL PHARMACEUTICALS (AVDL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 137,500 | — | 0% | 0.90% | $2.1M | $15.27 |
| 2025 Q2 | UNCHANGED | 137,500 | — | 0% | 0.54% | $1.2M | $8.85 |
| 2025 Q1 | ADDED | 137,500 | +500 | +0.4% | 0.48% | $1.1M | $7.83 |
| 2024 Q4 | UNCHANGED | 137,000 | — | 0% | 0.53% | $1.4M | $10.51 |
| 2024 Q3 | UNCHANGED | 137,000 | — | 0% | 0.75% | $1.8M | $13.11 |
| 2024 Q2 | UNCHANGED | 137,000 | — | 0% | 0.87% | $1.9M | $14.06 |
| 2024 Q1 | ADDED | 137,000 | +41,000 | +42.7% | 1.01% | $2.3M | $16.89 |
| 2023 Q4 | UNCHANGED | 96,000 | — | 0% | 0.65% | $1.4M | $14.12 |
| 2023 Q3 | UNCHANGED | 96,000 | — | 0% | 0.50% | $989K | $10.30 |
| 2023 Q2 | UNCHANGED | 96,000 | — | 0% | 0.74% | $1.6M | $16.48 |
As of 2025 Q4 — sorted by position size